These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 24394010)

  • 1. [Risk factors for tumor recurrence after curative resection in patients with Stage IIIa colon and rectosigmoid cancer].
    Shigemasa Y; Oyama S; Hashimoto Y; Kusaba T; Kajihara K; Sasaki N; Ikari H; Kunizaki T; Yonemitsu N
    Gan To Kagaku Ryoho; 2013 Nov; 40(12):2053-5. PubMed ID: 24394010
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Prognostic risk factors associated with recurrence after curative resection in patients with stage II colorectal cancer].
    Koyama M; Morita T; Hashizume T; Ito S; Tohyama S; Inaba Y; Oishi S; Morohashi H; Sakamoto Y; Murata A; Hakamada K
    Gan To Kagaku Ryoho; 2013 Nov; 40(12):1650-2. PubMed ID: 24393877
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical impact of elastic laminal invasion in colon cancer: elastic laminal invasion-positive stage II colon cancer is a high-risk equivalent to stage III.
    Yokota M; Kojima M; Nomura S; Nishizawa Y; Kobayashi A; Ito M; Ochiai A; Saito N
    Dis Colon Rectum; 2014 Jul; 57(7):830-8. PubMed ID: 24901683
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Analysis of prognostic factors after radical resection in 628 patients with stage II or III colon cancer].
    Qin Q; Yang L; Zhou AP; Sun YK; Song Y; DU F; Wang JW
    Zhonghua Zhong Liu Za Zhi; 2013 Mar; 35(3):212-6. PubMed ID: 23880003
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumor budding as an index to identify high-risk patients with stage II colon cancer.
    Nakamura T; Mitomi H; Kanazawa H; Ohkura Y; Watanabe M
    Dis Colon Rectum; 2008 May; 51(5):568-72. PubMed ID: 18286339
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preoperative irradiation and surgery for local recurrence of rectal and rectosigmoid cancer. Prognostic factors with regard to survival and further local recurrence.
    Wiig JN; Larsen SG; Dueland S; Giercksky KE
    Colorectal Dis; 2008 Jan; 10(1):48-57. PubMed ID: 18028472
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic significance of multiple molecular markers for patients with stage II colorectal cancer undergoing curative resection.
    Uen YH; Lin SR; Wu DC; Su YC; Wu JY; Cheng TL; Chi CW; Wang JY
    Ann Surg; 2007 Dec; 246(6):1040-6. PubMed ID: 18043108
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of patients with high-risk stage II colon cancer for adjuvant therapy.
    Quah HM; Chou JF; Gonen M; Shia J; Schrag D; Landmann RG; Guillem JG; Paty PB; Temple LK; Wong WD; Weiser MR
    Dis Colon Rectum; 2008 May; 51(5):503-7. PubMed ID: 18322753
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Operative salvage for locoregional recurrent colon cancer after curative resection: an analysis of 100 cases.
    Bowne WB; Lee B; Wong WD; Ben-Porat L; Shia J; Cohen AM; Enker WE; Guillem JG; Paty PB; Weiser MR
    Dis Colon Rectum; 2005 May; 48(5):897-909. PubMed ID: 15785892
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Univariate and multivariate regression analyses of recurrence and metastasis of colon cancer after radical resection].
    Ren JQ; Zhou ZW; Wan DS; Lu ZH; Chen G; Wang GQ; Tang SX; Wang JJ
    Ai Zheng; 2006 May; 25(5):591-5. PubMed ID: 16687080
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinicopathological risk factors of Stage II colon cancer: results of a prospective study.
    Santos C; López-Doriga A; Navarro M; Mateo J; Biondo S; Martínez Villacampa M; Soler G; Sanjuan X; Paules MJ; Laquente B; Guinó E; Kreisler E; Frago R; Germà JR; Moreno V; Salazar R
    Colorectal Dis; 2013 Apr; 15(4):414-22. PubMed ID: 22974322
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Improved prediction of recurrence after curative resection of colon carcinoma using tree-based risk stratification.
    Radespiel-Tröger M; Hohenberger W; Reingruber B
    Cancer; 2004 Mar; 100(5):958-67. PubMed ID: 14983491
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The clinical outcome and prognostic factors after multi-visceral resection for advanced colon cancer.
    Yun SH; Yun HR; Lee WS; Cho YB; Lee WY; Chun HK
    Eur J Surg Oncol; 2009 Jul; 35(7):721-7. PubMed ID: 18385008
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Factors predicting oncologic outcomes in patients with fewer than 12 lymph nodes retrieved after curative resection for colon cancer.
    Huh JW; Kim CH; Kim HR; Kim YJ
    J Surg Oncol; 2012 Feb; 105(2):125-9. PubMed ID: 21837680
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Studies on the results of operations for carcinoma of the sigmoid colon].
    Ouchi A; Sakuma A; Sugawara T; Kawakami K; Shiiba K; Ebina N; Shimizu F; Ito H; Sato T
    Gan No Rinsho; 1984 Aug; 30(10):1274-9. PubMed ID: 6481962
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk factor analysis of locoregional recurrence after sublobar resection in patients with clinical stage IA non-small cell lung cancer.
    Koike T; Koike T; Yoshiya K; Tsuchida M; Toyabe S
    J Thorac Cardiovasc Surg; 2013 Aug; 146(2):372-8. PubMed ID: 23870323
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Distribution of lymph node metastases is an independent predictor of survival for sigmoid colon and rectal cancer.
    Huh JW; Kim YJ; Kim HR
    Ann Surg; 2012 Jan; 255(1):70-8. PubMed ID: 22133895
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multivisceral resection for colon carcinoma.
    Croner RS; Merkel S; Papadopoulos T; Schellerer V; Hohenberger W; Goehl J
    Dis Colon Rectum; 2009 Aug; 52(8):1381-6. PubMed ID: 19617748
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Defining a high-risk subgroup with colon cancer stages I and II for possible adjuvant therapy.
    Gertler R; Rosenberg R; Schuster T; Friess H
    Eur J Cancer; 2009 Nov; 45(17):2992-9. PubMed ID: 19682890
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Study of a high-risk group of stage II colon cancer.
    Hirosawa T; Itabashi M; Bamba Y; Ogawa S; Sirotani N; Kameoka S
    Int Surg; 2009; 94(2):130-5. PubMed ID: 20108615
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.